Delivery Order SPE2DB24D2216-SPE2DB25FGPCW
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of QULIPTA 60 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $15,675.35 and a period of performance through March 31, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen holds a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of QULIPTA 60 MG TABLET 30S, a medication, with a firm fixed price of $5,558.55 and a period of performance through May 16, 2025. The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,788.48, is for the delivery of QULIPTA 60 MG TABLET 30S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of February 4, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of QULIPTA 30 MG TABLET 30S. The contract has a ceiling value of $1,020.58 and a completion date of July 7, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of QULIPTA 60 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $5,417.24 and a period of performance through July 3, 2025. The award is not set-aside and was made on July 2, 2025. Amerisourcebergen Drug Corp is the prime contractor and holds a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the pharmaceutical product QULIPTA 60 MG TABLET 30S, with a ceiling value of $5,523.86 and a performance period through June 11, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of QULIPTA 60 MG TABLET 30S. The $1,154.79 firm fixed-price contract has a completion date of July 11, 2025 and is not set aside for a specific business type. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a wide range of pharmaceutical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of QULIPTA 60 MG TABLET 30S, a pharmaceutical product. The contract has a firm fixed price, a ceiling value of $18,085.73, and a period of performance extending to July 7, 2025. This contract is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of QULIPTA 60 MG TABLET 30S. The $2,131.38 firm-fixed-price contract has a completion date of July 17, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999, for delivering a wide range of medical commodities to support military...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of QULIPTA 60 MG TABLET 30S, a medical product, with a ceiling value of $7,633.22 and a period of performance through March 13, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA...
- SPE2DB24D2216Indefinite Delivery Contract
- SPE2DB24D2216-SPE2DB25FGPCWDelivery Order
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of QULIPTA 60 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $12,506.67 and a period of performance through July 7, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp is the prime contractor, and this award is associated with the company's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.5k | 7/3/25 |